10-27860841-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_018076.5(ODAD2):​c.2805C>A​(p.Asn935Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 1,613,642 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0079 ( 13 hom., cov: 32)
Exomes 𝑓: 0.00075 ( 21 hom. )

Consequence

ODAD2
NM_018076.5 missense

Scores

7
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0890

Publications

5 publications found
Variant links:
Genes affected
ODAD2 (HGNC:25583): (outer dynein arm docking complex subunit 2) The protein encoded by this gene contains ten Armadillo repeat motifs (ARMs) and one HEAT repeat, and is thought to be involved in ciliary and flagellar movement. This protein has been shown to localize to the ciliary axonemes and at the ciliary base of respiratory cells. Studies indicate that mutations in this gene cause partial outer dynein arm (ODA) defects in respiratory cilia. The cilia of cells with mutations in this gene displayed either reduced ciliary beat frequency and amplitude, or, complete immotility. Some individuals with primary ciliary dyskensia (PCD) have been shown to have mutations in this gene. PCD is characterized by chronic airway disease and left/right body asymmetry defects. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
ODAD2 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 23
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047443807).
BP6
Variant 10-27860841-G-T is Benign according to our data. Variant chr10-27860841-G-T is described in ClinVar as Benign. ClinVar VariationId is 417172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00786 (1197/152258) while in subpopulation AFR AF = 0.0274 (1138/41544). AF 95% confidence interval is 0.0261. There are 13 homozygotes in GnomAd4. There are 553 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD2NM_018076.5 linkc.2805C>A p.Asn935Lys missense_variant Exon 19 of 20 ENST00000305242.10 NP_060546.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD2ENST00000305242.10 linkc.2805C>A p.Asn935Lys missense_variant Exon 19 of 20 1 NM_018076.5 ENSP00000306410.5

Frequencies

GnomAD3 genomes
AF:
0.00787
AC:
1198
AN:
152140
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0275
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00176
AC:
442
AN:
250760
AF XY:
0.00129
show subpopulations
Gnomad AFR exome
AF:
0.0250
Gnomad AMR exome
AF:
0.000753
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000265
Gnomad OTH exome
AF:
0.000654
GnomAD4 exome
AF:
0.000746
AC:
1090
AN:
1461384
Hom.:
21
Cov.:
31
AF XY:
0.000644
AC XY:
468
AN XY:
727006
show subpopulations
African (AFR)
AF:
0.0268
AC:
897
AN:
33460
American (AMR)
AF:
0.000939
AC:
42
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53400
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000153
AC:
17
AN:
1111598
Other (OTH)
AF:
0.00194
AC:
117
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
55
109
164
218
273
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00786
AC:
1197
AN:
152258
Hom.:
13
Cov.:
32
AF XY:
0.00743
AC XY:
553
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0274
AC:
1138
AN:
41544
American (AMR)
AF:
0.00262
AC:
40
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68014
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
66
132
197
263
329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00315
Hom.:
12
Bravo
AF:
0.00893
ESP6500AA
AF:
0.0252
AC:
111
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00231
AC:
281
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:1
Aug 23, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

not provided Benign:1
Feb 03, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Primary ciliary dyskinesia 23 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
3.1
DANN
Benign
0.95
DEOGEN2
Benign
0.025
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.85
T
MetaRNN
Benign
0.0047
T
MetaSVM
Benign
-0.44
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
0.089
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-3.2
D
REVEL
Uncertain
0.29
Sift
Uncertain
0.0090
D
Sift4G
Uncertain
0.017
D
Vest4
0.45
ClinPred
0.057
T
GERP RS
-9.0
PromoterAI
0.027
Neutral
Varity_R
0.26
gMVP
0.38
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35181927; hg19: chr10-28149770; COSMIC: COSV99044453; API